OBJECTIVE: Neuropsychiatric symptoms are commonly associated with chronic hepatitis C
virus infection, its sequelae, and its treatment. In particular, interferon, a primary component …

BACKGROUND: Peginterferon and ribavirin treatment of chronic hepatitis C (CHC) is
frequently associated with dose-limiting neuropsychiatric toxicity. The purpose of this study …

Objective: To carry out a systematic review of the risk factors for, and incidence of, major
depressive episode (MDE) related to antiviral therapy for chronic hepatitis C. Data Sources …

Objectives The aim of this study is to examine the role of different bio-psycho-social risk
factors for the onset of depression among patients with Hepatitis C (HCV) treated with …

Background Although rare, psychosis can emerge during interferon (IFN)-alpha therapy and
persist after therapy is completed. Objective The authors report the case of a 30-year-old …

Background: Interferon-induced depression represents a major complication in antiviral
treatment of chronic hepatitis C virus (HCV) infection. Aim: To evaluate in a placebo …

Background Hepatitis C is a major health problem in Egypt and worldwide. Hepatitis C is
associated with an increased prevalence of psychiatric disorders, particularly depression. In …

OBJECTIVE: This study evaluated the distinctive clinical and biological manifestations of
depressive symptom subtypes (ie, cognitive–affective and somatic) in Veterans with hepatitis …

Background. Treatment with low-dose interferon alpha (IFN-α) is often associated with
neuropsychiatric side effects. In addition to depression and anxiety, IFN-α associated …

Background The highest number of hepatits C virus all over the world is in Egypt.
Depression, which occurs during the course of illness, can affect the treatment response …